nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—migraine—Prednisone—atopic dermatitis	0.764	1	CpDpCtD
Rizatriptan—Hypertension—Hydrocortisone—atopic dermatitis	0.000137	0.000663	CcSEcCtD
Rizatriptan—Discomfort—Prednisolone—atopic dermatitis	0.000137	0.000661	CcSEcCtD
Rizatriptan—Angioedema—Triamcinolone—atopic dermatitis	0.000137	0.00066	CcSEcCtD
Rizatriptan—Angioedema—Methylprednisolone—atopic dermatitis	0.000136	0.000659	CcSEcCtD
Rizatriptan—Erythema—Dexamethasone—atopic dermatitis	0.000136	0.000656	CcSEcCtD
Rizatriptan—Erythema—Betamethasone—atopic dermatitis	0.000136	0.000656	CcSEcCtD
Rizatriptan—Myalgia—Hydrocortisone—atopic dermatitis	0.000135	0.000654	CcSEcCtD
Rizatriptan—Hallucination—Prednisone—atopic dermatitis	0.000135	0.000653	CcSEcCtD
Rizatriptan—Anxiety—Hydrocortisone—atopic dermatitis	0.000135	0.000651	CcSEcCtD
Rizatriptan—Vertigo—Triamcinolone—atopic dermatitis	0.000134	0.000649	CcSEcCtD
Rizatriptan—Syncope—Triamcinolone—atopic dermatitis	0.000134	0.000648	CcSEcCtD
Rizatriptan—Vertigo—Methylprednisolone—atopic dermatitis	0.000134	0.000648	CcSEcCtD
Rizatriptan—Syncope—Methylprednisolone—atopic dermatitis	0.000134	0.000647	CcSEcCtD
Rizatriptan—Discomfort—Hydrocortisone—atopic dermatitis	0.000134	0.000646	CcSEcCtD
Rizatriptan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000133	0.000641	CcSEcCtD
Rizatriptan—Oedema—Prednisolone—atopic dermatitis	0.000133	0.000641	CcSEcCtD
Rizatriptan—Vomiting—Tacrolimus—atopic dermatitis	0.000132	0.000639	CcSEcCtD
Rizatriptan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000132	0.000635	CcSEcCtD
Rizatriptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000131	0.000634	CcSEcCtD
Rizatriptan—Rash—Tacrolimus—atopic dermatitis	0.000131	0.000633	CcSEcCtD
Rizatriptan—Dermatitis—Tacrolimus—atopic dermatitis	0.000131	0.000633	CcSEcCtD
Rizatriptan—Shock—Prednisolone—atopic dermatitis	0.000131	0.000631	CcSEcCtD
Rizatriptan—Cough—Triamcinolone—atopic dermatitis	0.000131	0.000631	CcSEcCtD
Rizatriptan—Headache—Tacrolimus—atopic dermatitis	0.00013	0.000629	CcSEcCtD
Rizatriptan—Oedema—Hydrocortisone—atopic dermatitis	0.00013	0.000627	CcSEcCtD
Rizatriptan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.00013	0.000627	CcSEcCtD
Rizatriptan—Convulsion—Triamcinolone—atopic dermatitis	0.00013	0.000626	CcSEcCtD
Rizatriptan—Tachycardia—Prednisolone—atopic dermatitis	0.00013	0.000626	CcSEcCtD
Rizatriptan—Convulsion—Methylprednisolone—atopic dermatitis	0.000129	0.000625	CcSEcCtD
Rizatriptan—Hypertension—Triamcinolone—atopic dermatitis	0.000129	0.000624	CcSEcCtD
Rizatriptan—Hypertension—Methylprednisolone—atopic dermatitis	0.000129	0.000623	CcSEcCtD
Rizatriptan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000128	0.00062	CcSEcCtD
Rizatriptan—Shock—Hydrocortisone—atopic dermatitis	0.000128	0.000616	CcSEcCtD
Rizatriptan—Myalgia—Triamcinolone—atopic dermatitis	0.000127	0.000615	CcSEcCtD
Rizatriptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000127	0.000614	CcSEcCtD
Rizatriptan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000127	0.000614	CcSEcCtD
Rizatriptan—Myalgia—Methylprednisolone—atopic dermatitis	0.000127	0.000614	CcSEcCtD
Rizatriptan—Anxiety—Methylprednisolone—atopic dermatitis	0.000127	0.000612	CcSEcCtD
Rizatriptan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000127	0.000611	CcSEcCtD
Rizatriptan—Flushing—Prednisone—atopic dermatitis	0.000126	0.000609	CcSEcCtD
Rizatriptan—Discomfort—Triamcinolone—atopic dermatitis	0.000126	0.000608	CcSEcCtD
Rizatriptan—Discomfort—Methylprednisolone—atopic dermatitis	0.000126	0.000607	CcSEcCtD
Rizatriptan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000125	0.000606	CcSEcCtD
Rizatriptan—Dry mouth—Triamcinolone—atopic dermatitis	0.000125	0.000602	CcSEcCtD
Rizatriptan—Angioedema—Dexamethasone—atopic dermatitis	0.000124	0.000599	CcSEcCtD
Rizatriptan—Angioedema—Betamethasone—atopic dermatitis	0.000124	0.000599	CcSEcCtD
Rizatriptan—Anorexia—Hydrocortisone—atopic dermatitis	0.000124	0.000597	CcSEcCtD
Rizatriptan—Nausea—Tacrolimus—atopic dermatitis	0.000124	0.000597	CcSEcCtD
Rizatriptan—Angiopathy—Prednisone—atopic dermatitis	0.000123	0.000595	CcSEcCtD
Rizatriptan—Confusional state—Methylprednisolone—atopic dermatitis	0.000123	0.000593	CcSEcCtD
Rizatriptan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000122	0.00059	CcSEcCtD
Rizatriptan—Oedema—Triamcinolone—atopic dermatitis	0.000122	0.00059	CcSEcCtD
Rizatriptan—Vertigo—Dexamethasone—atopic dermatitis	0.000122	0.000589	CcSEcCtD
Rizatriptan—Vertigo—Betamethasone—atopic dermatitis	0.000122	0.000589	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000122	0.000589	CcSEcCtD
Rizatriptan—Syncope—Betamethasone—atopic dermatitis	0.000122	0.000588	CcSEcCtD
Rizatriptan—Syncope—Dexamethasone—atopic dermatitis	0.000122	0.000588	CcSEcCtD
Rizatriptan—Arrhythmia—Prednisone—atopic dermatitis	0.000121	0.000586	CcSEcCtD
Rizatriptan—Shock—Triamcinolone—atopic dermatitis	0.00012	0.00058	CcSEcCtD
Rizatriptan—Insomnia—Prednisolone—atopic dermatitis	0.00012	0.00058	CcSEcCtD
Rizatriptan—Shock—Methylprednisolone—atopic dermatitis	0.00012	0.000579	CcSEcCtD
Rizatriptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00012	0.000577	CcSEcCtD
Rizatriptan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000119	0.000576	CcSEcCtD
Rizatriptan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000119	0.000576	CcSEcCtD
Rizatriptan—Paraesthesia—Prednisolone—atopic dermatitis	0.000119	0.000576	CcSEcCtD
Rizatriptan—Tachycardia—Triamcinolone—atopic dermatitis	0.000119	0.000576	CcSEcCtD
Rizatriptan—Mental disorder—Prednisone—atopic dermatitis	0.000119	0.000575	CcSEcCtD
Rizatriptan—Tachycardia—Methylprednisolone—atopic dermatitis	0.000119	0.000574	CcSEcCtD
Rizatriptan—Erythema—Prednisone—atopic dermatitis	0.000118	0.000571	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000118	0.000571	CcSEcCtD
Rizatriptan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000118	0.00057	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000118	0.000569	CcSEcCtD
Rizatriptan—Convulsion—Dexamethasone—atopic dermatitis	0.000118	0.000568	CcSEcCtD
Rizatriptan—Convulsion—Betamethasone—atopic dermatitis	0.000118	0.000568	CcSEcCtD
Rizatriptan—Insomnia—Hydrocortisone—atopic dermatitis	0.000117	0.000567	CcSEcCtD
Rizatriptan—Hypertension—Dexamethasone—atopic dermatitis	0.000117	0.000566	CcSEcCtD
Rizatriptan—Hypertension—Betamethasone—atopic dermatitis	0.000117	0.000566	CcSEcCtD
Rizatriptan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000117	0.000563	CcSEcCtD
Rizatriptan—Myalgia—Betamethasone—atopic dermatitis	0.000116	0.000558	CcSEcCtD
Rizatriptan—Myalgia—Dexamethasone—atopic dermatitis	0.000116	0.000558	CcSEcCtD
Rizatriptan—Anxiety—Dexamethasone—atopic dermatitis	0.000115	0.000556	CcSEcCtD
Rizatriptan—Anxiety—Betamethasone—atopic dermatitis	0.000115	0.000556	CcSEcCtD
Rizatriptan—Discomfort—Betamethasone—atopic dermatitis	0.000114	0.000552	CcSEcCtD
Rizatriptan—Discomfort—Dexamethasone—atopic dermatitis	0.000114	0.000552	CcSEcCtD
Rizatriptan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000114	0.000551	CcSEcCtD
Rizatriptan—Pain—Prednisolone—atopic dermatitis	0.000114	0.000549	CcSEcCtD
Rizatriptan—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000113	0.000545	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000112	0.000541	CcSEcCtD
Rizatriptan—Fatigue—Hydrocortisone—atopic dermatitis	0.000112	0.00054	CcSEcCtD
Rizatriptan—Vision blurred—Prednisone—atopic dermatitis	0.000111	0.000538	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000111	0.000537	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000111	0.000536	CcSEcCtD
Rizatriptan—Pain—Hydrocortisone—atopic dermatitis	0.000111	0.000536	CcSEcCtD
Rizatriptan—Oedema—Dexamethasone—atopic dermatitis	0.000111	0.000535	CcSEcCtD
Rizatriptan—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000111	0.000535	CcSEcCtD
Rizatriptan—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000111	0.000535	CcSEcCtD
Rizatriptan—Oedema—Betamethasone—atopic dermatitis	0.000111	0.000535	CcSEcCtD
Rizatriptan—Insomnia—Triamcinolone—atopic dermatitis	0.00011	0.000534	CcSEcCtD
Rizatriptan—Insomnia—Methylprednisolone—atopic dermatitis	0.00011	0.000532	CcSEcCtD
Rizatriptan—Paraesthesia—Triamcinolone—atopic dermatitis	0.00011	0.00053	CcSEcCtD
Rizatriptan—Feeling abnormal—Prednisolone—atopic dermatitis	0.000109	0.000529	CcSEcCtD
Rizatriptan—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000109	0.000529	CcSEcCtD
Rizatriptan—Shock—Betamethasone—atopic dermatitis	0.000109	0.000527	CcSEcCtD
Rizatriptan—Shock—Dexamethasone—atopic dermatitis	0.000109	0.000527	CcSEcCtD
Rizatriptan—Dyspnoea—Triamcinolone—atopic dermatitis	0.000109	0.000526	CcSEcCtD
Rizatriptan—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000109	0.000525	CcSEcCtD
Rizatriptan—Nervous system disorder—Betamethasone—atopic dermatitis	0.000109	0.000525	CcSEcCtD
Rizatriptan—Agitation—Prednisone—atopic dermatitis	0.000109	0.000525	CcSEcCtD
Rizatriptan—Tachycardia—Dexamethasone—atopic dermatitis	0.000108	0.000522	CcSEcCtD
Rizatriptan—Tachycardia—Betamethasone—atopic dermatitis	0.000108	0.000522	CcSEcCtD
Rizatriptan—Angioedema—Prednisone—atopic dermatitis	0.000108	0.000522	CcSEcCtD
Rizatriptan—Dyspepsia—Triamcinolone—atopic dermatitis	0.000108	0.000519	CcSEcCtD
Rizatriptan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000107	0.000518	CcSEcCtD
Rizatriptan—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000107	0.000517	CcSEcCtD
Rizatriptan—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000107	0.000517	CcSEcCtD
Rizatriptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000107	0.000516	CcSEcCtD
Rizatriptan—Vertigo—Prednisone—atopic dermatitis	0.000106	0.000513	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000106	0.000512	CcSEcCtD
Rizatriptan—Syncope—Prednisone—atopic dermatitis	0.000106	0.000512	CcSEcCtD
Rizatriptan—Anorexia—Dexamethasone—atopic dermatitis	0.000106	0.00051	CcSEcCtD
Rizatriptan—Anorexia—Betamethasone—atopic dermatitis	0.000106	0.00051	CcSEcCtD
Rizatriptan—Urticaria—Prednisolone—atopic dermatitis	0.000106	0.00051	CcSEcCtD
Rizatriptan—Fatigue—Triamcinolone—atopic dermatitis	0.000105	0.000509	CcSEcCtD
Rizatriptan—Fatigue—Methylprednisolone—atopic dermatitis	0.000105	0.000507	CcSEcCtD
Rizatriptan—Pain—Triamcinolone—atopic dermatitis	0.000104	0.000504	CcSEcCtD
Rizatriptan—Loss of consciousness—Prednisone—atopic dermatitis	0.000104	0.000502	CcSEcCtD
Rizatriptan—Urticaria—Hydrocortisone—atopic dermatitis	0.000103	0.000498	CcSEcCtD
Rizatriptan—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000103	0.000495	CcSEcCtD
Rizatriptan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000103	0.000495	CcSEcCtD
Rizatriptan—Convulsion—Prednisone—atopic dermatitis	0.000102	0.000495	CcSEcCtD
Rizatriptan—Hypertension—Prednisone—atopic dermatitis	0.000102	0.000493	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000101	0.000488	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000101	0.000488	CcSEcCtD
Rizatriptan—Arthralgia—Prednisone—atopic dermatitis	0.000101	0.000486	CcSEcCtD
Rizatriptan—Myalgia—Prednisone—atopic dermatitis	0.000101	0.000486	CcSEcCtD
Rizatriptan—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000101	0.000486	CcSEcCtD
Rizatriptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.0001	0.000485	CcSEcCtD
Rizatriptan—Anxiety—Prednisone—atopic dermatitis	0.0001	0.000485	CcSEcCtD
Rizatriptan—Insomnia—Betamethasone—atopic dermatitis	0.0001	0.000484	CcSEcCtD
Rizatriptan—Insomnia—Dexamethasone—atopic dermatitis	0.0001	0.000484	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	9.97e-05	0.000481	CcSEcCtD
Rizatriptan—Paraesthesia—Betamethasone—atopic dermatitis	9.95e-05	0.000481	CcSEcCtD
Rizatriptan—Paraesthesia—Dexamethasone—atopic dermatitis	9.95e-05	0.000481	CcSEcCtD
Rizatriptan—Discomfort—Prednisone—atopic dermatitis	9.95e-05	0.00048	CcSEcCtD
Rizatriptan—Hypersensitivity—Prednisolone—atopic dermatitis	9.79e-05	0.000473	CcSEcCtD
Rizatriptan—Dyspepsia—Dexamethasone—atopic dermatitis	9.76e-05	0.000471	CcSEcCtD
Rizatriptan—Dyspepsia—Betamethasone—atopic dermatitis	9.76e-05	0.000471	CcSEcCtD
Rizatriptan—Urticaria—Triamcinolone—atopic dermatitis	9.71e-05	0.000469	CcSEcCtD
Rizatriptan—Urticaria—Methylprednisolone—atopic dermatitis	9.68e-05	0.000468	CcSEcCtD
Rizatriptan—Body temperature increased—Triamcinolone—atopic dermatitis	9.66e-05	0.000466	CcSEcCtD
Rizatriptan—Anaphylactic shock—Prednisone—atopic dermatitis	9.65e-05	0.000466	CcSEcCtD
Rizatriptan—Oedema—Prednisone—atopic dermatitis	9.65e-05	0.000466	CcSEcCtD
Rizatriptan—Abdominal pain—Methylprednisolone—atopic dermatitis	9.64e-05	0.000465	CcSEcCtD
Rizatriptan—Decreased appetite—Dexamethasone—atopic dermatitis	9.64e-05	0.000465	CcSEcCtD
Rizatriptan—Decreased appetite—Betamethasone—atopic dermatitis	9.64e-05	0.000465	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	9.57e-05	0.000462	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	9.57e-05	0.000462	CcSEcCtD
Rizatriptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	9.56e-05	0.000462	CcSEcCtD
Rizatriptan—Fatigue—Dexamethasone—atopic dermatitis	9.56e-05	0.000461	CcSEcCtD
Rizatriptan—Fatigue—Betamethasone—atopic dermatitis	9.56e-05	0.000461	CcSEcCtD
Rizatriptan—Shock—Prednisone—atopic dermatitis	9.5e-05	0.000459	CcSEcCtD
Rizatriptan—Pain—Dexamethasone—atopic dermatitis	9.48e-05	0.000458	CcSEcCtD
Rizatriptan—Pain—Betamethasone—atopic dermatitis	9.48e-05	0.000458	CcSEcCtD
Rizatriptan—Nervous system disorder—Prednisone—atopic dermatitis	9.47e-05	0.000457	CcSEcCtD
Rizatriptan—Tachycardia—Prednisone—atopic dermatitis	9.42e-05	0.000455	CcSEcCtD
Rizatriptan—Hyperhidrosis—Prednisone—atopic dermatitis	9.33e-05	0.000451	CcSEcCtD
Rizatriptan—Asthenia—Hydrocortisone—atopic dermatitis	9.31e-05	0.00045	CcSEcCtD
Rizatriptan—Anorexia—Prednisone—atopic dermatitis	9.2e-05	0.000444	CcSEcCtD
Rizatriptan—Pruritus—Hydrocortisone—atopic dermatitis	9.18e-05	0.000443	CcSEcCtD
Rizatriptan—Feeling abnormal—Dexamethasone—atopic dermatitis	9.13e-05	0.000441	CcSEcCtD
Rizatriptan—Feeling abnormal—Betamethasone—atopic dermatitis	9.13e-05	0.000441	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	9.06e-05	0.000438	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Betamethasone—atopic dermatitis	9.06e-05	0.000438	CcSEcCtD
Rizatriptan—Hypersensitivity—Triamcinolone—atopic dermatitis	9e-05	0.000435	CcSEcCtD
Rizatriptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.98e-05	0.000434	CcSEcCtD
Rizatriptan—Diarrhoea—Hydrocortisone—atopic dermatitis	8.88e-05	0.000429	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—NPS—atopic dermatitis	8.82e-05	0.00302	CbGpPWpGaD
Rizatriptan—Urticaria—Betamethasone—atopic dermatitis	8.81e-05	0.000425	CcSEcCtD
Rizatriptan—Urticaria—Dexamethasone—atopic dermatitis	8.81e-05	0.000425	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.79e-05	0.000425	CcSEcCtD
Rizatriptan—Dizziness—Prednisolone—atopic dermatitis	8.78e-05	0.000424	CcSEcCtD
Rizatriptan—HTR1B—G alpha (i) signalling events—CCR5—atopic dermatitis	8.77e-05	0.003	CbGpPWpGaD
Rizatriptan—Asthenia—Triamcinolone—atopic dermatitis	8.77e-05	0.000423	CcSEcCtD
Rizatriptan—Body temperature increased—Betamethasone—atopic dermatitis	8.76e-05	0.000423	CcSEcCtD
Rizatriptan—Body temperature increased—Dexamethasone—atopic dermatitis	8.76e-05	0.000423	CcSEcCtD
Rizatriptan—Abdominal pain—Dexamethasone—atopic dermatitis	8.76e-05	0.000423	CcSEcCtD
Rizatriptan—Abdominal pain—Betamethasone—atopic dermatitis	8.76e-05	0.000423	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—CCR3—atopic dermatitis	8.75e-05	0.00299	CbGpPWpGaD
Rizatriptan—Asthenia—Methylprednisolone—atopic dermatitis	8.75e-05	0.000422	CcSEcCtD
Rizatriptan—Insomnia—Prednisone—atopic dermatitis	8.73e-05	0.000422	CcSEcCtD
Rizatriptan—Paraesthesia—Prednisone—atopic dermatitis	8.67e-05	0.000419	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—CXCR3—atopic dermatitis	8.65e-05	0.00296	CbGpPWpGaD
Rizatriptan—Pruritus—Triamcinolone—atopic dermatitis	8.64e-05	0.000417	CcSEcCtD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	8.64e-05	0.00295	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	8.64e-05	0.00295	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—TAC1—atopic dermatitis	8.64e-05	0.00295	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—NPS—atopic dermatitis	8.64e-05	0.00295	CbGpPWpGaD
Rizatriptan—Pruritus—Methylprednisolone—atopic dermatitis	8.62e-05	0.000416	CcSEcCtD
Rizatriptan—HTR1D—Signaling by GPCR—CCL27—atopic dermatitis	8.62e-05	0.00295	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCL10—atopic dermatitis	8.62e-05	0.00295	CbGpPWpGaD
Rizatriptan—Dizziness—Hydrocortisone—atopic dermatitis	8.58e-05	0.000414	CcSEcCtD
Rizatriptan—Dyspepsia—Prednisone—atopic dermatitis	8.5e-05	0.00041	CcSEcCtD
Rizatriptan—HTR1F—GPCR ligand binding—CCR5—atopic dermatitis	8.48e-05	0.0029	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	8.48e-05	0.0029	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCR3—atopic dermatitis	8.47e-05	0.0029	CbGpPWpGaD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCL8—atopic dermatitis	8.47e-05	0.0029	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCL27—atopic dermatitis	8.44e-05	0.00289	CbGpPWpGaD
Rizatriptan—Decreased appetite—Prednisone—atopic dermatitis	8.39e-05	0.000405	CcSEcCtD
Rizatriptan—Rash—Prednisolone—atopic dermatitis	8.38e-05	0.000404	CcSEcCtD
Rizatriptan—Dermatitis—Prednisolone—atopic dermatitis	8.37e-05	0.000404	CcSEcCtD
Rizatriptan—Diarrhoea—Methylprednisolone—atopic dermatitis	8.34e-05	0.000403	CcSEcCtD
Rizatriptan—Fatigue—Prednisone—atopic dermatitis	8.32e-05	0.000402	CcSEcCtD
Rizatriptan—Headache—Prednisolone—atopic dermatitis	8.32e-05	0.000402	CcSEcCtD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	8.31e-05	0.00284	CbGpPWpGaD
Rizatriptan—Constipation—Prednisone—atopic dermatitis	8.26e-05	0.000399	CcSEcCtD
Rizatriptan—Vomiting—Hydrocortisone—atopic dermatitis	8.25e-05	0.000398	CcSEcCtD
Rizatriptan—Rash—Hydrocortisone—atopic dermatitis	8.18e-05	0.000395	CcSEcCtD
Rizatriptan—Dermatitis—Hydrocortisone—atopic dermatitis	8.17e-05	0.000395	CcSEcCtD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	8.14e-05	0.00278	CbGpPWpGaD
Rizatriptan—Headache—Hydrocortisone—atopic dermatitis	8.13e-05	0.000392	CcSEcCtD
Rizatriptan—Dizziness—Triamcinolone—atopic dermatitis	8.08e-05	0.00039	CcSEcCtD
Rizatriptan—Dizziness—Methylprednisolone—atopic dermatitis	8.06e-05	0.000389	CcSEcCtD
Rizatriptan—HTR1F—Signaling Pathways—CCL27—atopic dermatitis	7.96e-05	0.00272	CbGpPWpGaD
Rizatriptan—Feeling abnormal—Prednisone—atopic dermatitis	7.95e-05	0.000384	CcSEcCtD
Rizatriptan—Asthenia—Betamethasone—atopic dermatitis	7.95e-05	0.000384	CcSEcCtD
Rizatriptan—Asthenia—Dexamethasone—atopic dermatitis	7.95e-05	0.000384	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—CCR3—atopic dermatitis	7.94e-05	0.00272	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.91e-05	0.0027	CbGpPWpGaD
Rizatriptan—Gastrointestinal pain—Prednisone—atopic dermatitis	7.89e-05	0.000381	CcSEcCtD
Rizatriptan—Nausea—Prednisolone—atopic dermatitis	7.89e-05	0.000381	CcSEcCtD
Rizatriptan—Pruritus—Dexamethasone—atopic dermatitis	7.84e-05	0.000379	CcSEcCtD
Rizatriptan—Pruritus—Betamethasone—atopic dermatitis	7.84e-05	0.000379	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—NPS—atopic dermatitis	7.8e-05	0.00267	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—TAC1—atopic dermatitis	7.8e-05	0.00267	CbGpPWpGaD
Rizatriptan—Vomiting—Triamcinolone—atopic dermatitis	7.77e-05	0.000375	CcSEcCtD
Rizatriptan—Vomiting—Methylprednisolone—atopic dermatitis	7.75e-05	0.000374	CcSEcCtD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.74e-05	0.00265	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL17—atopic dermatitis	7.73e-05	0.00264	CbGpPWpGaD
Rizatriptan—Nausea—Hydrocortisone—atopic dermatitis	7.71e-05	0.000372	CcSEcCtD
Rizatriptan—Rash—Triamcinolone—atopic dermatitis	7.7e-05	0.000372	CcSEcCtD
Rizatriptan—Dermatitis—Triamcinolone—atopic dermatitis	7.7e-05	0.000372	CcSEcCtD
Rizatriptan—Rash—Methylprednisolone—atopic dermatitis	7.69e-05	0.000371	CcSEcCtD
Rizatriptan—Dermatitis—Methylprednisolone—atopic dermatitis	7.68e-05	0.000371	CcSEcCtD
Rizatriptan—Urticaria—Prednisone—atopic dermatitis	7.67e-05	0.00037	CcSEcCtD
Rizatriptan—Headache—Triamcinolone—atopic dermatitis	7.65e-05	0.00037	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCR3—atopic dermatitis	7.65e-05	0.00261	CbGpPWpGaD
Rizatriptan—Headache—Methylprednisolone—atopic dermatitis	7.64e-05	0.000369	CcSEcCtD
Rizatriptan—Abdominal pain—Prednisone—atopic dermatitis	7.63e-05	0.000368	CcSEcCtD
Rizatriptan—Body temperature increased—Prednisone—atopic dermatitis	7.63e-05	0.000368	CcSEcCtD
Rizatriptan—Diarrhoea—Dexamethasone—atopic dermatitis	7.58e-05	0.000366	CcSEcCtD
Rizatriptan—Diarrhoea—Betamethasone—atopic dermatitis	7.58e-05	0.000366	CcSEcCtD
Rizatriptan—HTR1B—Signaling by GPCR—CCL17—atopic dermatitis	7.57e-05	0.00259	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	7.42e-05	0.00254	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	7.38e-05	0.00252	CbGpPWpGaD
Rizatriptan—Dizziness—Dexamethasone—atopic dermatitis	7.33e-05	0.000354	CcSEcCtD
Rizatriptan—Dizziness—Betamethasone—atopic dermatitis	7.33e-05	0.000354	CcSEcCtD
Rizatriptan—Nausea—Triamcinolone—atopic dermatitis	7.26e-05	0.00035	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—IL5—atopic dermatitis	7.25e-05	0.00248	CbGpPWpGaD
Rizatriptan—Nausea—Methylprednisolone—atopic dermatitis	7.24e-05	0.00035	CcSEcCtD
Rizatriptan—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	7.21e-05	0.00247	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL17—atopic dermatitis	7.14e-05	0.00244	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	7.12e-05	0.00244	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Prednisone—atopic dermatitis	7.11e-05	0.000343	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—NPS—atopic dermatitis	7.08e-05	0.00242	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—TAC1—atopic dermatitis	7.08e-05	0.00242	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	7.08e-05	0.00242	CbGpPWpGaD
Rizatriptan—Vomiting—Betamethasone—atopic dermatitis	7.05e-05	0.00034	CcSEcCtD
Rizatriptan—Vomiting—Dexamethasone—atopic dermatitis	7.05e-05	0.00034	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—CXCL10—atopic dermatitis	6.99e-05	0.00239	CbGpPWpGaD
Rizatriptan—Rash—Betamethasone—atopic dermatitis	6.99e-05	0.000337	CcSEcCtD
Rizatriptan—Rash—Dexamethasone—atopic dermatitis	6.99e-05	0.000337	CcSEcCtD
Rizatriptan—Dermatitis—Betamethasone—atopic dermatitis	6.98e-05	0.000337	CcSEcCtD
Rizatriptan—Dermatitis—Dexamethasone—atopic dermatitis	6.98e-05	0.000337	CcSEcCtD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.97e-05	0.00238	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	6.95e-05	0.00238	CbGpPWpGaD
Rizatriptan—Headache—Betamethasone—atopic dermatitis	6.94e-05	0.000335	CcSEcCtD
Rizatriptan—Headache—Dexamethasone—atopic dermatitis	6.94e-05	0.000335	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—CXCR3—atopic dermatitis	6.94e-05	0.00237	CbGpPWpGaD
Rizatriptan—Asthenia—Prednisone—atopic dermatitis	6.93e-05	0.000334	CcSEcCtD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.85e-05	0.00234	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCL10—atopic dermatitis	6.85e-05	0.00234	CbGpPWpGaD
Rizatriptan—Pruritus—Prednisone—atopic dermatitis	6.83e-05	0.00033	CcSEcCtD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.73e-05	0.0023	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	6.68e-05	0.00228	CbGpPWpGaD
Rizatriptan—Diarrhoea—Prednisone—atopic dermatitis	6.6e-05	0.000319	CcSEcCtD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.6e-05	0.00226	CbGpPWpGaD
Rizatriptan—Nausea—Dexamethasone—atopic dermatitis	6.58e-05	0.000318	CcSEcCtD
Rizatriptan—Nausea—Betamethasone—atopic dermatitis	6.58e-05	0.000318	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—IL5—atopic dermatitis	6.58e-05	0.00225	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	6.58e-05	0.00225	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	6.58e-05	0.00225	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	6.45e-05	0.00221	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	6.43e-05	0.0022	CbGpPWpGaD
Rizatriptan—Dizziness—Prednisone—atopic dermatitis	6.38e-05	0.000308	CcSEcCtD
Rizatriptan—HTR1F—Signaling Pathways—KIF3A—atopic dermatitis	6.37e-05	0.00218	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.33e-05	0.00216	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL11—atopic dermatitis	6.23e-05	0.00213	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.2e-05	0.00212	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	6.2e-05	0.00212	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCL10—atopic dermatitis	6.18e-05	0.00211	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	6.18e-05	0.00211	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FCER2—atopic dermatitis	6.15e-05	0.0021	CbGpPWpGaD
Rizatriptan—Vomiting—Prednisone—atopic dermatitis	6.14e-05	0.000296	CcSEcCtD
Rizatriptan—HTR1B—Signaling by GPCR—CCL11—atopic dermatitis	6.1e-05	0.00209	CbGpPWpGaD
Rizatriptan—Rash—Prednisone—atopic dermatitis	6.09e-05	0.000294	CcSEcCtD
Rizatriptan—Dermatitis—Prednisone—atopic dermatitis	6.08e-05	0.000294	CcSEcCtD
Rizatriptan—Headache—Prednisone—atopic dermatitis	6.05e-05	0.000292	CcSEcCtD
Rizatriptan—HTR1D—GPCR ligand binding—CCL5—atopic dermatitis	6.02e-05	0.00206	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FCER2—atopic dermatitis	6.02e-05	0.00206	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.9e-05	0.00202	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CCL5—atopic dermatitis	5.9e-05	0.00202	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	5.77e-05	0.00197	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CMA1—atopic dermatitis	5.76e-05	0.00197	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL11—atopic dermatitis	5.76e-05	0.00197	CbGpPWpGaD
Rizatriptan—Nausea—Prednisone—atopic dermatitis	5.73e-05	0.000277	CcSEcCtD
Rizatriptan—HTR1D—Signaling Pathways—CCL22—atopic dermatitis	5.71e-05	0.00195	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCL10—atopic dermatitis	5.61e-05	0.00192	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	5.61e-05	0.00192	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CCR3—atopic dermatitis	5.59e-05	0.00191	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL22—atopic dermatitis	5.59e-05	0.00191	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CCR3—atopic dermatitis	5.48e-05	0.00187	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CCR5—atopic dermatitis	5.42e-05	0.00185	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.42e-05	0.00185	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT6—atopic dermatitis	5.41e-05	0.00185	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.38e-05	0.00184	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CCL5—atopic dermatitis	5.32e-05	0.00182	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.31e-05	0.00182	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	5.31e-05	0.00182	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.3e-05	0.00181	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	5.22e-05	0.00178	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCL8—atopic dermatitis	5.13e-05	0.00175	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GLB1—atopic dermatitis	5.1e-05	0.00174	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL27—atopic dermatitis	5.09e-05	0.00174	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCR3—atopic dermatitis	5.08e-05	0.00174	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—TAC1—atopic dermatitis	4.99e-05	0.0017	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—NPS—atopic dermatitis	4.99e-05	0.0017	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	4.99e-05	0.0017	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	4.97e-05	0.0017	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCR3—atopic dermatitis	4.89e-05	0.00167	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ADSL—atopic dermatitis	4.89e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	4.88e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	4.88e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CCL5—atopic dermatitis	4.83e-05	0.00165	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CCR5—atopic dermatitis	4.79e-05	0.00164	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.79e-05	0.00164	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCR3—atopic dermatitis	4.69e-05	0.0016	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	4.65e-05	0.00159	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—IL5—atopic dermatitis	4.64e-05	0.00158	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.59e-05	0.00157	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	4.58e-05	0.00157	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL17—atopic dermatitis	4.57e-05	0.00156	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	4.54e-05	0.00155	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—TAC1—atopic dermatitis	4.53e-05	0.00155	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—NPS—atopic dermatitis	4.53e-05	0.00155	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.5e-05	0.00154	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.5e-05	0.00154	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	4.49e-05	0.00154	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	4.47e-05	0.00153	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCR3—atopic dermatitis	4.44e-05	0.00152	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	4.43e-05	0.00152	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	4.43e-05	0.00152	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CCR5—atopic dermatitis	4.35e-05	0.00149	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	4.35e-05	0.00149	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.31e-05	0.00147	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	4.26e-05	0.00146	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.22e-05	0.00144	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.22e-05	0.00144	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	4.21e-05	0.00144	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TAC1—atopic dermatitis	4.18e-05	0.00143	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NPS—atopic dermatitis	4.18e-05	0.00143	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	4.17e-05	0.00143	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	4.12e-05	0.00141	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCR3—atopic dermatitis	4.1e-05	0.0014	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	4.07e-05	0.00139	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	4.05e-05	0.00138	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.04e-05	0.00138	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	3.99e-05	0.00136	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	3.95e-05	0.00135	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.9e-05	0.00133	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL5—atopic dermatitis	3.89e-05	0.00133	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.87e-05	0.00132	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	3.8e-05	0.0013	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	3.79e-05	0.0013	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	3.72e-05	0.00127	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	3.72e-05	0.00127	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.71e-05	0.00127	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	3.68e-05	0.00126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	3.68e-05	0.00126	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.65e-05	0.00125	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	3.6e-05	0.00123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	3.6e-05	0.00123	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	3.59e-05	0.00123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	3.51e-05	0.0012	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	3.46e-05	0.00118	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	3.46e-05	0.00118	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	3.41e-05	0.00116	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	3.4e-05	0.00116	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	3.39e-05	0.00116	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	3.38e-05	0.00115	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	3.38e-05	0.00115	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	3.33e-05	0.00114	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL10—atopic dermatitis	3.32e-05	0.00113	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	3.31e-05	0.00113	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	3.28e-05	0.00112	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.21e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	3.21e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.15e-05	0.00108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	3.14e-05	0.00107	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	3.09e-05	0.00106	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	3.07e-05	0.00105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	3.04e-05	0.00104	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	3.03e-05	0.00103	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	3e-05	0.00103	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	3e-05	0.00103	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.95e-05	0.00101	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	2.94e-05	0.001	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCL8—atopic dermatitis	2.9e-05	0.000991	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL5—atopic dermatitis	2.85e-05	0.000976	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	2.78e-05	0.000952	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—IL2—atopic dermatitis	2.77e-05	0.000947	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	2.75e-05	0.000939	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	2.75e-05	0.000939	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	2.73e-05	0.000932	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	2.68e-05	0.000915	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NPS—atopic dermatitis	2.67e-05	0.000915	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	2.67e-05	0.000915	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NGF—atopic dermatitis	2.64e-05	0.000904	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCL8—atopic dermatitis	2.63e-05	0.0009	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	2.62e-05	0.000897	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NPS—atopic dermatitis	2.62e-05	0.000895	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	2.62e-05	0.000895	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	2.58e-05	0.000883	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCR5—atopic dermatitis	2.57e-05	0.000879	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	2.57e-05	0.000878	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.54e-05	0.000868	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL2—atopic dermatitis	2.51e-05	0.00086	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL5—atopic dermatitis	2.49e-05	0.00085	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.45e-05	0.000836	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL5—atopic dermatitis	2.43e-05	0.000833	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	2.3e-05	0.000788	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.29e-05	0.000782	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	2.24e-05	0.000765	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NFKBIA—atopic dermatitis	2.18e-05	0.000745	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	2.12e-05	0.000725	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	2.08e-05	0.00071	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	2.08e-05	0.00071	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NPS—atopic dermatitis	2e-05	0.000682	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	2e-05	0.000682	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.96e-05	0.000669	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.88e-05	0.000643	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.85e-05	0.000634	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.85e-05	0.000634	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.83e-05	0.000624	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.81e-05	0.00062	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.8e-05	0.000616	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.79e-05	0.000611	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.77e-05	0.000606	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000593	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.69e-05	0.000578	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.68e-05	0.000575	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.66e-05	0.000566	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARA—atopic dermatitis	1.65e-05	0.000566	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.65e-05	0.000563	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.64e-05	0.000562	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.00055	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.61e-05	0.00055	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.58e-05	0.000541	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.000538	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	1.55e-05	0.000532	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL2—atopic dermatitis	1.49e-05	0.000508	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	1.48e-05	0.000505	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.39e-05	0.000477	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.38e-05	0.000473	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.37e-05	0.000468	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	1.37e-05	0.000468	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.36e-05	0.000467	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.36e-05	0.000465	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.32e-05	0.000452	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.26e-05	0.000431	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.000429	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1.23e-05	0.000419	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	1.2e-05	0.00041	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.04e-05	0.000356	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	9.94e-06	0.00034	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	9.73e-06	0.000333	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—atopic dermatitis	9.5e-06	0.000325	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	9.45e-06	0.000323	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—atopic dermatitis	9.3e-06	0.000318	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	9.26e-06	0.000316	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	8.74e-06	0.000299	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—atopic dermatitis	8.73e-06	0.000299	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	8.56e-06	0.000293	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	7.42e-06	0.000254	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—atopic dermatitis	7.09e-06	0.000242	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	7.05e-06	0.000241	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	6.52e-06	0.000223	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARA—atopic dermatitis	6.1e-06	0.000209	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—atopic dermatitis	5.58e-06	0.000191	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—atopic dermatitis	5.47e-06	0.000187	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—atopic dermatitis	4.17e-06	0.000142	CbGpPWpGaD
